MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

MDS Virtual Congress 2021

September 17-22, 2021. Virtual Congress. www.mdscongress.org

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Mobile application for assessing the likelihood of developing depression in patients with Parkinson’s disease

    M. Nikitina, A. Bragin, E. Bragina, V. Alifirova, N. Zhukova, D. Gomboeva, V. Spitsyn (Tomsk, Russian Federation)

  • Model Innovation in Parkinson’s disease drug development: linking Quantitative Systems Pharmacology to the patient voice

    J. Barrett, B. Piccoli, M. Muller, K. Barrett, D. Goncharov, C. Kaddi, K. Azer, K. Romero, D. Stephenson (Tucson, USA)

  • Modeling of the Placebo Response in Parkinson’s Disease

    S. Branders, O. Rascol, G. Garraux, B. Berman, G. Stebbins, C. Goetz, C. Billocq, A. Pereira (Mont-Saint-Guibert, Belgium)

  • Molecular changes of a de novo missense variant in VPS16 in dystonia

    H. Pott, K. Zeuner, C. örün, S. Paschen, S. Diaw, K. Plötze-Martin, M. Borsche, G. Kuhlenbäumer, C. Klein, N. Brüggemann, M. Klinger, K. Lohmann (Lübeck, Germany)

  • Molecular investigation of apparently healthy heterozygous Parkin mutation carriers

    M. Castelo, A. Zanon, V. Gilmozzi, C. Klein, P. Pramstaller, A. Hicks, I. Pichler (Bolzano, Italy)

  • MOLECULAR-GENETIC ASPECTS OF WILSON’S DISEASE IN UKRAINE

    I. Voloshyn-Haponov (Kharkiv, Ukraine)

  • Monitoring electrophysiological parameters in PD patients enrolled for MRgFUS: l’Aquila-tor Vergata experience

    R. Cerroni, P. Sucapane, M. Conti, D. Cerone, C. Liguori, A. Stefani, C. Marini (Rome, Italy)

  • Monogenic Hub of the Global Parkinson’s Genetics Program (GP2): The 500-genomes pilot project

    L. Lange, K. Lohmann, EM. Valente, SY. Lim, AH. Tan, EJ. Vollstedt, M. Avenali, H. Madoev, P. Heutink, K. Kumar, N. Mencacci, C. Klein (Luebeck, Germany)

  • Monogenic Portal of the Global Parkinson’s Genetics Program (GP2)

    SY. Lim, LM. Lange, H. Madoev, KR. Kumar, AH. Tan, M. Avenali, P. Heutink, EJ. Vollstedt, K. Lohmann, N. Mencacci, C. Klein, EM. Valente (Kuala Lumpur, Malaysia)

  • Mood is a Key Factor in Progression of Non-Motor Symptoms Burden in Parkinson´s disease.

    D. Santos García, C. Cores, T. de Deus, J. Paz González, C. Martínez, E. Suárez, S. Jesús, M. Aguilar, P. Pastor, L. Planellas, M. Cosgaya, J. García Caldentey, N. Caballol, I. Legarda, J. Hernández Vara, I. Cabo, L. López Manzanares, I. González Aramburu, M. Avila, M. Catalán, V. Nogueira, V. Puente, J. García Moreno, C. Borrué, B. Solano, M. álvarez Sauco, L. Vela, S. Escalante, E. Cubo, F. Carrillo, J. Martínez Castrillo, P. Sánchez Alonso, G. Alonso Losada, N. López Ariztegui, I. Gastón, J. Kulisevsky, M. Blázquez, M. Seijo, J. Ruíz Martínez, C. Valero, M. Kurtis, O. de Fábregues, J. González, C. Ordás, L. López Díaz, P. Mir, P. Martínez Martín, C. Coppadis (A Coruña, Spain)

  • « Previous Page
  • 1
  • …
  • 75
  • 76
  • 77
  • 78
  • 79
  • …
  • 132
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • #24752 (not found)
    • Effect of Aspartame on Parkinson’s Disease Progression and Severity
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley